| Identification | Back Directory | [Name]
2-(4-fluorophenyl)-3-oxo-2,3-dihydropyridazine-4-carboxylic acid | [CAS]
946505-09-5 | [Synonyms]
2-(4-fluorophenyl)-3-oxo-2,3-dihydropyridazine-4-carboxylic acid 4-Pyridazinecarboxylic acid, 2-(4-fluorophenyl)-2,3-dihydro-3-oxo- | [Molecular Formula]
C11H7FN2O3 | [MDL Number]
MFCD26096712 | [MOL File]
946505-09-5.mol | [Molecular Weight]
234.18 |
| Hazard Information | Back Directory | [Synthesis]
Step C: Preparation of 2-(4-fluorophenyl)-3-oxo-2,3-dihydropyridazine-4-carboxylic acid; (E)-5-(2-(2-(4-fluorophenyl)hydrazinylidene)ethylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione (0.60 g, 2.05 mmol) was mixed with NaOMe (0.133 g, 2.46 mmol) in a MeOH (10 mL) solution were mixed and heated to reflux for 15 hours. After completion of the reaction, the reaction mixture was treated with cold 1N HCl solution, and the organic phase was extracted with CH2Cl2, dried over MgSO4, and concentrated to give 0.42 g (87% yield) of the target compound.1H NMR (400 MHz, CDCl3) δ 13.57 (br s, 1H), 8.29 (m, 2H), 7.63 (m, 2H), 7.24 ( m, 2H); 19F NMR (376 MHz, CDCl3) δ -110.7. lRMS (ESI pos) m/e 235.1 (M + 1). | [References]
[1] Patent: US2007/197537, 2007, A1. Location in patent: Page/Page column 91 [2] Patent: US2007/238726, 2007, A1. Location in patent: Page/Page column 68 [3] Patent: WO2009/33084, 2009, A1. Location in patent: Page/Page column 81 |
|
| Company Name: |
BioPharmaMatrix,Inc.
|
| Telephone: |
0510-86010668 13395169561; |
| Website: |
http://www.biopharmamatrix.com |
| Company Name: |
Bide Pharmatech Ltd.
|
| Telephone: |
400-1647117 13681763483 |
| Website: |
https://www.bidepharm.com/ |
|